BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pedron CN, de Oliveira CS, da Silva AF, Andrade GP, da Silva Pinhal MA, Cerchiaro G, da Silva Junior PI, da Silva FD, Torres MDT, Oliveira VX. The effect of lysine substitutions in the biological activities of the scorpion venom peptide VmCT1. European Journal of Pharmaceutical Sciences 2019;136:104952. [DOI: 10.1016/j.ejps.2019.06.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Zhu N, Zhong C, Liu T, Zhu Y, Gou S, Bao H, Yao J, Ni J. Newly designed antimicrobial peptides with potent bioactivity and enhanced cell selectivity prevent and reverse rifampin resistance in Gram-negative bacteria. European Journal of Pharmaceutical Sciences 2021;158:105665. [DOI: 10.1016/j.ejps.2020.105665] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mikaelian AG, Traboulay E, Zhang XM, Yeritsyan E, Pedersen PL, Ko YH, Matalka KZ. Pleiotropic Anticancer Properties of Scorpion Venom Peptides: Rhopalurus princeps Venom as an Anticancer Agent. Drug Des Devel Ther 2020;14:881-93. [PMID: 32161447 DOI: 10.2147/DDDT.S231008] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Pedron CN, Silva AF, Torres MT, Oliveira CS, Andrade GP, Cerchiaro G, Pinhal MAS, de la Fuente-Nunez C, Oliveira Junior VX. Net charge tuning modulates the antiplasmodial and anticancer properties of peptides derived from scorpion venom. J Pept Sci 2021;27:e3296. [PMID: 33442881 DOI: 10.1002/psc.3296] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Aghamiri S, Zandsalimi F, Raee P, Abdollahifar MA, Tan SC, Low TY, Najafi S, Ashrafizadeh M, Zarrabi A, Ghanbarian H, Bandehpour M. Antimicrobial peptides as potential therapeutics for breast cancer. Pharmacol Res 2021;171:105777. [PMID: 34298112 DOI: 10.1016/j.phrs.2021.105777] [Reference Citation Analysis]
5 Oliveira CS, Torres MT, Pedron CN, Andrade VB, Silva PI Jr, Silva FD, de la Fuente-Nunez C, Oliveira VX Jr. Synthetic Peptide Derived from Scorpion Venom Displays Minimal Toxicity and Anti-infective Activity in an Animal Model. ACS Infect Dis 2021;7:2736-45. [PMID: 34463484 DOI: 10.1021/acsinfecdis.1c00261] [Reference Citation Analysis]
6 Erviana R, Saengkun Y, Rungsa P, Jangpromma N, Tippayawat P, Klaynongsruang S, Daduang J, Daduang S. Novel Antimicrobial Peptides from a Cecropin-Like Region of Heteroscorpine-1 from Heterometrus laoticus Venom with Membrane Disruption Activity. Molecules 2021;26:5872. [PMID: 34641415 DOI: 10.3390/molecules26195872] [Reference Citation Analysis]
7 Furtado AA, Daniele-silva A, Resende de Oliveira IR, Mendes RFV, Gomes dos Santos EC, de Carvalho E, Damasceno IZ, e Silva Parente AM, da Fonseca Ribeiro de Sena KX, da Silva-júnior AA, Ximenes RM, Vieira DS, de Freitas Fernandes-pedrosa M. In silico and in vitro structure-stability-function relationship of analog peptides of Stigmurin and its antibacterial and antibiofilm activities. Pharmacological Research 2022. [DOI: 10.1016/j.phrs.2022.106245] [Reference Citation Analysis]
8 Jiménez-Vargas JM, Ramírez-Carreto S, Corzo G, Possani LD, Becerril B, Ortiz E. Structural and functional characterization of NDBP-4 family antimicrobial peptides from the scorpion Mesomexovis variegatus. Peptides 2021;141:170553. [PMID: 33862164 DOI: 10.1016/j.peptides.2021.170553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Monteiro ML, Lima DB, Freire KA, Nicolaski Pedron C, Magalhães EP, Silva BP, García-jareño AB, Silva Oliveira C, Nunes JVS, Marinho MM, Menezes RRPPBD, Orzaéz M, Oliveira Junior VX, Martins AMC. Rational design of a trypanocidal peptide derived from Dinoponera quadriceps venom. European Journal of Medicinal Chemistry 2022. [DOI: 10.1016/j.ejmech.2022.114624] [Reference Citation Analysis]
10 Manrique-Moreno M, Santa-González GA, Gallego V. Bioactive cationic peptides as potential agents for breast cancer treatment. Biosci Rep 2021;41:BSR20211218C. [PMID: 34874400 DOI: 10.1042/BSR20211218C] [Reference Citation Analysis]
11 Serna N, Carratalá JV, Conchillo-Solé O, Martínez-Torró C, Unzueta U, Mangues R, Ferrer-Miralles N, Daura X, Vázquez E, Villaverde A. Antibacterial Activity of T22, a Specific Peptidic Ligand of the Tumoral Marker CXCR4. Pharmaceutics 2021;13:1922. [PMID: 34834337 DOI: 10.3390/pharmaceutics13111922] [Reference Citation Analysis]
12 Zhan N, Wang T, Zhang L, Shan A. A eukaryotic expression strategy for producing the novel antimicrobial peptide PRW4. Braz J Microbiol 2020;51:999-1008. [PMID: 32415637 DOI: 10.1007/s42770-020-00291-4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
13 Mirzaei S, Fekri HS, Hashemi F, Hushmandi K, Mohammadinejad R, Ashrafizadeh M, Zarrabi A, Garg M. Venom peptides in cancer therapy: An updated review on cellular and molecular aspects. Pharmacol Res 2021;164:105327. [PMID: 33276098 DOI: 10.1016/j.phrs.2020.105327] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Cesaro A, Torres MDT, Gaglione R, Dell'Olmo E, Di Girolamo R, Bosso A, Pizzo E, Haagsman HP, Veldhuizen EJA, de la Fuente-Nunez C, Arciello A. Synthetic Antibiotic Derived from Sequences Encrypted in a Protein from Human Plasma. ACS Nano 2022;16:1880-95. [PMID: 35112568 DOI: 10.1021/acsnano.1c04496] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
15 Zhang QY, Yan ZB, Meng YM, Hong XY, Shao G, Ma JJ, Cheng XR, Liu J, Kang J, Fu CY. Antimicrobial peptides: mechanism of action, activity and clinical potential. Mil Med Res 2021;8:48. [PMID: 34496967 DOI: 10.1186/s40779-021-00343-2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Carratalá JV, Serna N, Villaverde A, Vázquez E, Ferrer-Miralles N. Nanostructured antimicrobial peptides: The last push towards clinics. Biotechnol Adv 2020;44:107603. [PMID: 32738381 DOI: 10.1016/j.biotechadv.2020.107603] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 9.5] [Reference Citation Analysis]